CXCR4 and atherosclerosis: Li and colleagues proposed CXCR4 as an interesting theranostic target for atherosclerosis since CXCR4-directed endoradiotherapy with 177Lu-/90Y-pentixather for hematologic malignancies showed an anti-inflammatory effect on atherosclerotic plaques [25].